Clobetasol Propionate Aerosol, Foam
Product Images NDC 45802-437

9 FDA label images from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Clobetasol Propionate (NDC 45802-437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9f0 Structure

9f0 Structure
Chemical structure diagram of clobetasol propionate, showing its molecular configuration including ketone, fluoro, and chloro functional groups, consistent with its identity as a topical corticosteroid ingredient.*
FDA Label Image

Ctn 9f0 Rev12 19

Ctn 9f0 Rev12 19
Clobetasol Propionate Foam 0.05% topical aerosol foam packaging label by Padagis Israel Pharmaceuticals Ltd. The label shows the product name, active ingredient strength 0.05%, usage restrictions for topical use only, and warnings including flammability. It includes the net weight of 50 g and displays the NDC 45802-437-32. Directions for use and storage instructions are shown, along with the Perrigo logo and barcode.*
FDA Label Image

Figure A (Image 01)

Figure A (Image 01)
A product packaging panel instructing to insert the product's serial number (S/N), lot number, and expiration date (Exp). The placeholders indicate where this information should be added for tracking and identification purposes.*
FDA Label Image

Figure B (Image 02)

Figure B (Image 02)
An instructional illustration showing hands preparing a topical aerosol foam bottle for use. One hand holds the bottle upright while the other hand removes or places the nozzle cap on top. The image demonstrates handling the Clobetasol Propionate aerosol foam container prior to application.*
FDA Label Image

Figure C (Image 03)

Figure C (Image 03)
Black and white instructional image showing a person dispensing foam from a topical aerosol can into a dosing cup, demonstrating usage for a medication applied to the skin.*
FDA Label Image

Figure D (Image 04)

Figure D (Image 04)
Black and white illustration showing a person applying foam medication to their bent elbow using a finger. The image demonstrates topical application technique for aerosol foam products like Clobetasol Propionate topical foam.*
FDA Label Image

Figure E (Image 05)

Figure E (Image 05)
An instructional illustration showing a person applying a topical foam medication to the forearm using a small pad or cotton ball. The image demonstrates proper technique for topical application of Clobetasol Propionate aerosol foam on the skin.*
FDA Label Image

Figure F (Image 06)

Figure F (Image 06)
An instructional illustration showing a person applying topical foam to a scalp area. The image depicts the hand positioning for administering the foam on a scalp with a visible section of hair, suggesting directions for use of Clobetasol Propionate aerosol foam.*
FDA Label Image

Image 07

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.